Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastoma.

Jamin Y, Tucker ER, Poon E, Popov S, Vaughan L, Boult JK, Webber H, Hallsworth A, Baker LC, Jones C, Koh DM, Pearson AD, Chesler L, Robinson SP.

Radiology. 2013 Jan;266(1):130-40. doi: 10.1148/radiol.12120128. Epub 2012 Nov 20.

2.

Molecular imaging of neuroblastoma progression in TH-MYCN transgenic mice.

Quarta C, Cantelli E, Nanni C, Ambrosini V, D'ambrosio D, Di Leo K, Angelucci S, Zagni F, Lodi F, Marengo M, Weiss WA, Pession A, Tonelli R, Fanti S.

Mol Imaging Biol. 2013 Apr;15(2):194-202. doi: 10.1007/s11307-012-0576-9.

3.

miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs.

Terrile M, Bryan K, Vaughan L, Hallsworth A, Webber H, Chesler L, Stallings RL.

PLoS One. 2011;6(12):e28356. doi: 10.1371/journal.pone.0028356. Epub 2011 Dec 2.

4.

Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.

Li SP, Taylor NJ, Makris A, Ah-See ML, Beresford MJ, Stirling JJ, d'Arcy JA, Collins DJ, Padhani AR.

Radiology. 2010 Dec;257(3):643-52. doi: 10.1148/radiol.10100421. Epub 2010 Sep 21.

PMID:
20858850
5.

Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction.

Chesler L, Goldenberg DD, Collins R, Grimmer M, Kim GE, Tihan T, Nguyen K, Yakovenko S, Matthay KK, Weiss WA.

Neoplasia. 2008 Nov;10(11):1268-74.

6.

Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma.

Rasmuson A, Segerström L, Nethander M, Finnman J, Elfman LH, Javanmardi N, Nilsson S, Johnsen JI, Martinsson T, Kogner P.

PLoS One. 2012;7(12):e51297. doi: 10.1371/journal.pone.0051297. Epub 2012 Dec 17.

7.

Comparison of two vascular-disrupting agents at a clinically relevant dose in rodent liver tumors with multiparametric magnetic resonance imaging biomarkers.

Wang H, Cona MM, Chen F, Yu J, Feng Y, Li J, Keyzer FD, Marchal G, Ni Y.

Anticancer Drugs. 2012 Jan;23(1):12-21. doi: 10.1097/CAD.0b013e328349dd60.

PMID:
21857503
8.

Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity.

Messiou C, Orton M, Ang JE, Collins DJ, Morgan VA, Mears D, Castellano I, Papadatos-Pastos D, Brunetto A, Tunariu N, Mann H, Tessier J, Young H, Ghiorghiu D, Marley S, Kaye SB, deBono JS, Leach MO, deSouza NM.

Radiology. 2012 Nov;265(2):426-36. doi: 10.1148/radiol.12112565. Epub 2012 Aug 13.

PMID:
22891356
9.

Orthotopic pleural mesothelioma in mice: SPECT/CT and MR imaging with HER1- and HER2-targeted radiolabeled antibodies.

Nayak TK, Bernardo M, Milenic DE, Choyke PL, Brechbiel MW.

Radiology. 2013 Apr;267(1):173-82. doi: 10.1148/radiol.12121021. Epub 2013 Jan 17.

10.

Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones.

Guo Y, Zhang Y, Nijm GM, Sahakian AV, Yang GY, Omary RA, Larson AC.

Radiology. 2011 Feb;258(2):461-8. doi: 10.1148/radiol.10100645. Epub 2010 Dec 3.

11.

Reducing metallic artifacts in postoperative spinal imaging: usefulness of IDEAL contrast-enhanced T1- and T2-weighted MR imaging--phantom and clinical studies.

Cha JG, Jin W, Lee MH, Kim DH, Park JS, Shin WH, Yi BH.

Radiology. 2011 Jun;259(3):885-93. doi: 10.1148/radiol.11101856. Epub 2011 Mar 8.

PMID:
21386053
12.

Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging.

Thoeny HC, De Keyzer F, Vandecaveye V, Chen F, Sun X, Bosmans H, Hermans R, Verbeken EK, Boesch C, Marchal G, Landuyt W, Ni Y.

Radiology. 2005 Nov;237(2):492-9. Epub 2005 Sep 28.

PMID:
16192323
13.

Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.

Chesler L, Goldenberg DD, Seales IT, Satchi-Fainaro R, Grimmer M, Collins R, Struett C, Nguyen KN, Kim G, Tihan T, Bao Y, Brekken RA, Bergers G, Folkman J, Weiss WA.

Cancer Res. 2007 Oct 1;67(19):9435-42.

14.

Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.

Hoeks CM, Hambrock T, Yakar D, Hulsbergen-van de Kaa CA, Feuth T, Witjes JA, Fütterer JJ, Barentsz JO.

Radiology. 2013 Jan;266(1):207-17. doi: 10.1148/radiol.12120281. Epub 2012 Nov 9.

PMID:
23143029
15.

Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.

Huang W, Tudorica LA, Li X, Thakur SB, Chen Y, Morris EA, Tagge IJ, Korenblit ME, Rooney WD, Koutcher JA, Springer CS Jr.

Radiology. 2011 Nov;261(2):394-403. doi: 10.1148/radiol.11102413. Epub 2011 Aug 9.

16.

Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.

Akisik MF, Sandrasegaran K, Bu G, Lin C, Hutchins GD, Chiorean EG.

Radiology. 2010 Aug;256(2):441-9. doi: 10.1148/radiol.10091733. Epub 2010 Jun 1.

PMID:
20515976
17.

Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma.

Carlson LM, Rasmuson A, Idborg H, Segerström L, Jakobsson PJ, Sveinbjörnsson B, Kogner P.

Carcinogenesis. 2013 May;34(5):1081-8. doi: 10.1093/carcin/bgt009. Epub 2013 Jan 24.

18.

Neuroblastoma models for insights into tumorigenesis and new therapies.

Kiyonari S, Kadomatsu K.

Expert Opin Drug Discov. 2015 Jan;10(1):53-62. doi: 10.1517/17460441.2015.974544. Epub 2014 Oct 25. Review.

PMID:
25345447
19.

Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging.

Curvo-Semedo L, Lambregts DM, Maas M, Thywissen T, Mehsen RT, Lammering G, Beets GL, Caseiro-Alves F, Beets-Tan RG.

Radiology. 2011 Sep;260(3):734-43. doi: 10.1148/radiol.11102467. Epub 2011 Jun 14.

PMID:
21673229
20.
Items per page

Supplemental Content

Write to the Help Desk